Increasing Cases of Retroperitoneal Fibrosis After Covid-19: Case Report, Did She Die Retroperitoneal Fibrosis or Cancer?

Authors : Gülnihal Deniz, Mürteza Çakır, Serpil Bılgın Akyagcı

Pages : 12-15

Doi:10.33706/jemcr.1419408

View : 60 | Download : 68

Publication Date : 2024-03-29

Article Type : Other Papers

Abstract :This case report details the unfortunate journey of a 59-year-old breast cancer survivor who developed secondary Retroperitoneal Fibrosis (RPF) in 2022. Despite diligent treatment efforts, her condition took a devastating turn when, in June 2023, she was diagnosed not only with persistent RPF but also with advanced liver, omental, and duodenal cancer. Tragically, her condition deteriorated rapidly, leading to her passing on day 41 following her presentation. This case underscores the challenges of diagnosing and treating RPF. It highlights the importance of considering cancer development in advanced RPF cases that do not respond to treatment, often leaving limited options for effective intervention.
Keywords : Retroperitoneal Fibrosis, Liver Cancer, Metastasis, Steroid, Azathioprine